Safety and Immunogenicity of SCB-2019 in Children < 18 Years of Age

Condition:   COVID-19 Intervention:   Biological: Candidate vaccine, SCB-2019 Sponsor:   Clover Biopharmaceuticals AUS Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials